Chris Stevens – Chief Executive Officer & Executive Director – Coda Minerals (ASX:COD) is an advanced exploration company primed to unlock the value of the highly prospective Elizabeth Creek Copper Cobalt Project in South Australia’s world class mining jurisdiction, the Gawler Craton.
Copyright 2024 – Finance News Network
Source: Finance News Network
06 Aug 2024 - Alderan Resources Limited (ASX:AD8) Managing Director Scott Caithness discusses the company's exploration targets and progress.
Read More16 Jun 2022 - Knosys Limited (ASX:KNO) Managing Director John Thompson provides an update on the company, discussing demand drivers, recurring revenue and growth strategy.
Read More16 Sep 2019 - LBT Innovations Limited (ASX:LBT) Managing Director and CEO, Brent Barnes, talks FY19 results and outlook, including adoption of the company's culture plate reading device APAS Independence, the sales process and regulatory approval.
Read More24 Oct 2019 - BOTTY Limited Founder & CEO, Cary Gee, talks about his Conversational Commerce solution for merchants and how it leverages existing social messaging platforms to create an integrated customer engagement, analytics, payment and delivery solution.
Read More29 Sep 2020 - Elixinol Global Limited (ASX:EXL) CEO Oliver Horn provides an updates on trading conditions across the company's key markets, its new distribution agreement in the UK with the Well Pharmacy Group, and early success with its CBD (cannabidiol ) skincare range.
Read More27 May 2021 - Next Science Limited (ASX:NXS) Founder and Chief Technology Officer Dr Matthew Myntti talks about the problem of biofilms, Next Science's antimicrobial treatments and the company's recent FDA approval.
Read More29 Feb 2024 - Mitch Thomas - CFO - Latin Resources (ASX:LRS) is exploring and developing sustainable minerals in Australia and Latin America to provide the planet with environmentally friendly products.
Read More19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.
Read More15 Apr 2020 - MLC Senior Economist Bob Cunneen discusses the ongoing impact of the coronavirus on markets including central bank and government measures.
Read More17 May 2022 - PropTech Group Limited (ASX:PTG) Managing Director and Group CEO Joe Hanna discusses drivers behind PropTech's results, providing an update on the company's growth strategies.
Read More
